Al-Janabi, H., Exel, N.J.A. van, Brouwer, W.B.F., Trotter, C., Glennie, L., Hannigan, L. & Coast, J. (2015). A framework for including health spillovers in economic evaluation. Medical Decision Making. doi: 10.1177/0272989X15605094

Al-Janabi, H., Exel, N.J.A. van, Brouwer, W.B.F., Trotter, C., Glennie, L., Hannigan, L. & Coast, J. (2015). Measuring health spillovers for economic evaluation: A case study in meningitis. Health Economics. doi: 10.1002/hec.3259

Armstrong, N, Burgers, L.T., Deshpande, S, Al, M.J., Riemsma, R, Vallabhaneni, S.R., Holt, P, Severens, J.L. & Kleijnen, J. (2015). The use of fenestrated and branched endovascular aneurysm repairfor juxtarental and thoracoabdominal aneurysms: a systematic review and cost-effectiveness analysis. Health Technology Assessment, 18 (70). doi: 10.3310/hta18700

Asmus, K.J.E., Flinterman, L.E., Koopmanschap, M.A., Nieboer, A.P., Bakker, T.J., Mackenbach, J.P. & Steyerberg, E.W. (2015). Evaluation of the Prevention and Reactivation Care Program (PReCaP) for the hospitalized elderly: a prospective nonrandomized controlled trial. Clinical Interventions in Aging, 10, 649-661. doi: 10.2147/CIA.S77677

Attema, A.E., Brouwer, W.B.F., l’Haridon, O. & Pinto-Prades, J.L. (2015). Estimating sign-dependent societal preferences for quality of life. Journal of Health Economics, 43, 229-243. doi: 10.1016/j.jhealeco.2015.07.006

Attema, A.E. (2015). Incorporating sign-dependence in health-related social welfare functions. Expert review of pharmacoeconomics & outcomes research, 15 (2), 223-228. doi:

Baal, P.H.M. van, Peters, F., Mackenbach, J.P. & Nusselder, W.J. (2016). Forecasting differences in life expectancy by education. Population Studies. A Journal of Demography. doi: 10.1080/00324728.2016.1159718

Baal, P.H.M. van, Meltzer, D. & Brouwer, W.B.F. (2016). Future costs, fixed healthcare budgets and the decision rules of cost-effectiveness analysis. Health Economics, 25 (2), 237-248. doi: DOI: 10.1002/hec.3138

Baal, P.H.M. van, Hoogendoorn, M. & Fischer, A. (2016). Preventing dementia by promoting physical activity and the long-term impact on health and social care expenditures. Preventive Medicine, 85 (4), 78-83. doi:

Baal, P.H.M. van, Exel, N.J.A. van & Brouwer, W.B.F. (2015). Kosten van langer leven en de evaluatie van medische  technologie. (External report, Opinion Paper 64). Tilburg: Netspar.

Baillon, A. & Bleichrodt, H. (2015). Testing ambiguity models through the measurement of probabilities for gains and losses. American Economic Journal. Microeconomics, 7 (2), 77-100. doi:

Bakx, P.L.H. (2015, May 01). Financial Incentives in Long-Term Care. EUR. Prom./coprom.: E. van Doorslaer & prof.dr. F.T. Schut.

Balink, H., Tan, S.S., Veeger, NJGM, Holleman, F, Bennink, RJ, van Eck-Smit, B.L.F. & Verberne, HJ (2015). 18F-FDG PET/CT in inflammation of unknown origin: a cost-efficacy pilot-study. European Journal of Nuclear Medicine and Molecular Imaging, Aug;42 (9), 1408-1413.

Berghout, M.A., Exel, N.J.A. van, Leensvaart, L. & Cramm, J.M. (2015). Healthcare professionals’ views on patient-centered care in hospitals. Healthcare professionals’ views on patient-centered care in hospitals. Bmc Health Services Research, 15 (1), 385. doi: 10.1186/s12913-015-1049-z

Bleichrodt, H., Rohde, K.I.M., Spinu, V., Keskin, U. & Wakker, P.P. (2015). Discounted Utility and Present Value—A Close Relation. Operations Research, 63 (6), 1420-1430. doi:

Bleichrodt, H. & Wakker, P.P. (2015). Regret Theory: A Bold Alternative to the Alternatives. The Economic Journal, 125, 493-532. doi:

Blommestein, H.M., Franken, M.G. & Uyl – de Groot, C.A. (2015). A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry. Pharmacoeconomics (Print). doi: DOI 10.1007/s40273-015-0260-4

Blommestein, H.M., Verelst, S.G.R., Groot, S. de, Huijgens, P.C., Sonneveld, P. & Uyl – de Groot, C.A. (2015). A cost-effectiveness analysis of real-world treatment for elderly patients with multiple myeloma using a full disease model. European Journal of Haematology, 96 (2), 198-208. doi: 10.1111/ejh.12571

Boland, M.R.S., van Boven, J.F., Kocks, J.W., Van der Molen, T., Goossens, L.M.A., Chavannes, NH & Rutten – van Molken, M.P.M.H. (2015). Mapping the clinical chronic obstructive pulmonary disease questionnaire onto generic preference-based EQ-5D values. Value in Health, 18 (2), 299-307. doi: 10.1016/j.jval.2014.11.006

Boland, M.R.S.. Cost-effectiveness of Disease Management Programs in COPD. EUR. Prom./coprom.: prof.dr. M.P.M.H. Rutten – van Molken & NH Chavannes.

Bongers, M.L., Coupe, V.M.H., Ruysscher, D De, Oberije, C, Lambin, P & Uyl – de Groot, C.A. (2015). Individualized Positron Emission Tomography–Based Isotoxic Accelerated Radiation Therapy Is Cost-Effective Compared With Conventional Radiation Therapy: A Model-Based Evaluation. International Journal of Radiation Oncology Biology Physics, 91 (4), 857-865. doi:

Bongers, M.L., Ruysscher, D De, Oberije, C, Lambin, P, Uyl – de Groot, C.A. & Coupe, V.M.H. (2015). Multistate Statistical Modeling: A Tool to Build a Lung Cancer Microsimulation Model That Includes Parameter Uncertainty and Patient Heterogeneity. Medical Decision Making, 1-15. doi: 10.1177/0272989X15574500

Bouwmans, C.A.M., Sonneville-Koedoot, C. de, Mulder, C.L. & Hakkaart-van Roijen, L. (2015). Employment and the associated impact on quality of life in people diagnosed with schizophrenia. Neuropsychiatric Disease and Treatment, 11, 2125-2142. doi: 10.2147/NDT.S83546

Bouwmans, C.A.M., Krol, H.M., Severens, J.L., Koopmanschap, M.A., Brouwer, W.B.F. & Hakkaart-van Roijen, L. (2015). The iMTA Productivity Cost Questionnaire A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses. Value in Health. doi:

Bredenkamp, C. & Buisman, L.R. (2016). Financial protection from health spending in the Philippines: policies and progress. Health Policy and Planning. doi: 10.1093/heapol/czw011

Bredenkamp, C. & Buisman, L.R. (2015). Universal Health Coverage in the Philippines: Progress on Financial Protection Goals. (Working Paper, Policy Research Working Paper, no 7258). : World Bank.

Brown, SR, Danielson, S & Exel, N.J.A. van (2015). Overly ambitious critics and the Medici Effect: a reply to Kampen and Tamás. Quality and Quantity, 49 (2), 523-537. doi:

Buisman, L.R., Rijnsburger, A.J., den Hertog, H.M., Van der Lugt, A. & Redekop, W.K. (2015). Clinical Practice Variation Needs to be Considered in Cost-Effectiveness Analyses: A Case Study of Patients with a Recent Transient Ischemic Attack or Minor Ischemic Stroke. Applied Health Economics and Health Policy. doi:

Buisman, L.R., Tan, S.S., Nederkoorn, P.J., Koudstaal, P.J. & Redekop, W.K. (2015). Hospital costs of ischemic stroke and TIA in the Netherlands. Neurology, 84 (22), 2208-2215. doi:

Buisman, L.R. & Garcia Gomez, P. (2015). Inequity in inpatient healthcare utilisation 10 years after Apartheid. Development Southern Africa, 32 (2), 193-208. doi:

Buisman, L.R., Rutten-van Mölken, M.P., Postmus, D., Luime, J.J., Uyl-de Groot, C.A. & Redekop, W.K. (2016). The early bird catches the worm: early cost-effectiveness analysis of new medical tests. International Journal of Technology Assessment in Health Care, 32 (1). doi: 10.1017/S0266462316000064

Burgers, L.T., Mc Clellan, E., Hoefer, IE, Pasterkamp, G., Jukema, J.W., Horsman, S., Pijls, NHJ, Waltenberger, J, Hillaert, M., Stubbs, A, Severens, J.L. & Redekop, W.K. (2015). Treatment variation in stent choice in patients with stable or unstable coronary artery disease. Netherlands Heart Journal, 24, 110-119. doi: 10.1007/s12471-015-0783-5

Burgers, L.T.. Challenges in Assessing the Cost-Effectiveness of cardiovascular disease technologies. EUR (Enschede: Ipskamp drukkers). Prom./coprom.: prof.dr. J.L. Severens & dr. W.K. Redekop.

Corro Ramos, I., Rutten – van Molken, M.P.M.H. & Al, M.J. (2015). Determining the Impact of Modeling Additional Sources of Uncertainty in Value-of-Information Analysis. Value in Health, 18 (1), 100-109. doi: 10.1016/j.jval.2014.09.003.

Cramm, J.M., Leensvaart, L., Berghout, M.A. & Exel, N.J.A. van (2015). Exploring views on what is important for patient-centred care in end-stage renal disease using Q methodology. BMC Nephrology, 16, 74. doi: 10.1186/s12882-015-0071-z

Deenen, M.J., Meulendijks, Didier, Cats, A., Sechterberger, M.K., Severens, J.L., Boot, Henk, Smits, P.H., Rossing, Hilde, Mandigers, C.M.P.W., Soesan, Marcel, Beijen, J.H. & Schellens, J.H.M. (2015). Upfront Genotyping of DPYD* 2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis. Journal of Clinical Oncology, 34 (3). doi:

Exel, N.J.A. van, Baker, R., Mason, H., Donaldson, C. & Brouwer, W.B.F. (2015). Public views on principles for health care priority setting: Findings of a European cross-country study using Q methodology. Social Science & Medicine, 126, 128-137. doi:

Fennema, P., Heyse, T.J. & Uyl – de Groot, C.A. (2014). Cost-effectiveness and clinical implications of advanced bearings in total knee arthroplasty: a long-term modeling analysis. International Journal of Technology Assessment in Health Care, 30 (2), 218-225. doi: 10.1017/S0266462314000129

Frederix, G.W.J., Hovels, A.M., Severens, J.L., Raaijmakers, J.A.M. & Schellens, J.H.M. (2015). Drempelwaarde bij vergoeding van nieuwe medicatie. Nederlands Tijdschrift voor Geneeskunde, 2015 (159).

Frederix, G.W.J., Severens, J.L. & Hovels, A.M. (2015). Use of quality checklists and need for disease-specific guidance in economic evaluations: a meta-review. Expert review of pharmacoeconomics & outcomes research, 675-685. doi:

Freijer, K., Lenoir-Wijnkoop, I., Russell, C.A., Koopmanschap, M.A., Kruizenga, H.M., Lhachimi, S.K, Norman, K, Nuijten, M.J.C. & Schols, J.M.G.A. (2015). The view of European experts regarding health economics for medical nutrition in disease related malnutrition. European Journal of Clinical Nutrition, 69 (5), 539-545. doi:

Garrido-García, S., Sánchez-Martínez, F.I., Abellán-Perpiñán, J.M. & Exel, N.J.A. van (2015). Monetary valuation of informal care based on carers’ and non-carers’ preferences. Value in Health, 18 (6), 832-840. doi: 10.1016/j.jval.2015.05.001

Gaultney, J.G. & Uyl – de Groot, C.A. (2013). Efficient allocation of novel agents in multiple myeloma: a work in progress. Oncologist, 18 (1), 5-7. doi: 10.1634/theoncologist.2012-0484.

Gaultney, J.G., Franken, M.G., Uyl – de Groot, C.A., Redekop, W.K., Huijgens, P.C., Holt, B. van der, Lokhorst, H.M. & Sonneveld, P. (2015). Experience with outcomes research into the real-world effectiveness of novel therapies in Dutch daily practice from the context of conditional reimbursement. Health Policy, 119 (2), 186-194. doi:

Gheorghe, M., Wubulihasimu, P., Peters, F., Nusselder, W.J. & Baal, P.H.M. van (2016). Health inequalities in the Netherlands: trends in quality-adjusted life expectancy (QALE) by educational level. European Journal of Public Health. doi:

Goebbels, A.F.G., Exel, N.J.A. van, Ament, A.J.H.A., Vries, N.K de, Bot, S.D.M. & Severens, J.L. (2015). Consumer willingness to invest money and time for benefits of lifestyle behaviour change: an application of the contingent valuation method. Health Expectations, 18 (6), 2252-2265. doi:

Goor, K.M., Gaultney, J.G., van Houten, P., Wagg, A.S., Huygens, S.A., Nielen, M.M., Albers-Heitner, C.P., Redekop, W.K., Rutten – van Molken, M.P.M.H. & Al, M.J. (2015). Cost-Effectiveness of Including a Nurse Specialist in the Treatment of Urinary Incontinence in Primary Care in the Netherlands. PLoS One (print). doi:

Goor, K.M., Schaafsma, M.R., Joosten, P., Posthuma, E.F., Wittebol, S., Huijgens, P.C., Mattijssen, E.J., Vreugdenhil, G., Peters, WG, Erjavec, Z., Wijermans, P.W., Daenen, S.M. & van der Hem, K.G. (2015). Quality of life of patients with chronic lymphocytic leukaemia in the Netherlands: results of a longitudinal multicentre study. Quality of Life Research.

Goor, K.M.. Health Technology Assessment of health care innovations in Chronic Lymphocytic Leukaemia and Glaucoma Care: The value of mixed methods research. EUR. Prom./coprom.: Prof.dr. C.A. Uyl – de Groot & dr. M.A. Koopmanschap.

Goossens, L.M.A., Redekop, W.K. & van Gils, C.W.M. (2015). Noncollapsibility and Censoring: What’s the Bias in Estimating Effects on Survival? Epidemiology, 26 (1), e1-e2. doi: 10.1097/EDE.0000000000000197.

Grijpma, J.W., Tielen, M., Staa, A.L. van, Maasdam, L., Gelder, T. van, Berger, S.P., Busschbach, J.J. van, Betjes, M.G.H., Weimar, W. & Massey, E.K. (2016). Kidney Transplant Patients’ Attitudes towards Self-Management Support: A Q-Methodological Study. Patient Education and Counseling. doi: 10.1016/j.pec.2015.11.018

Güngör, D., Kruijshaar, M.E., Plug, I., Rizopoulos, D., Kanters, T.A., Wens, S.C.A., Reuser, A.J.J., van Doorn, P.A. & Ploeg, A.T. van der (2016). Quality of life and participation in daily life of adults with Pompe disease receiving enzyme replacement therapy: 10 years of international follow-up. Journal of Inherited Metabolic Disease, 39 (2), 253-260. doi: DOI 10.1007/s10545-015-9889-6

Haaren-ten Haken, T.M. van, Hendrix, M., Smits, LJ, Nieuwenhuijze, M.J., Severens, J.L., Vries, R.G. de & Nijhuis, J.G. (2015). The influence of preferred place of birth on the course of pregnancy and labor among healthy nulliparous women: a prospective cohort study. BMC Pregnancy and Childbirth, 15 (33). doi:

Handels, R.L.H., Joore, M.A., Tran-Duy, A., Wimo, A., Wolfs, C.A.G., Verhey, F.R.J. & Severens, J.L. (2015). Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimers disease biamarkers for hypothtical disease-modifying treatment decisionin mild cognitive impairment. Alzheimers  & Dementia, 896-905. doi:

Hendriks, M.E., Bolarinwa, O.A., Nelissen, H., Boers, A.C., Gomez, G.B., Tan, S.S., Redekop, W.K., Adenusi, P., Lange, J.M.A., Agbede, K., Akande, T.M. & Schultsz, C (2015). Costs of cardiovascular disease prevention care and scenarios for cost saving: a micro-costing study from rural Nigeria. Journal of Hypertension, Feb;33 (2), 376-684. doi: 10.1097/HJH.0000000000000402

Hoefman, R.J.. The impact of caregiving: the measurement and valuation of informal care for use in economic evaluations. EUR. Prom./coprom.: prof.dr. W.B.F. Brouwer & dr. N.J.A. van Exel.

Kanters, T.A., Redekop, W.K., Rutten – van Molken, M.P.M.H., Kruijshaar, M.E., Güngör, D., Ploeg, A.T. van der & Hakkaart-van Roijen, L. (2015). A conceptual disease model for adult Pompe disease. Orphanet Journal of Rare Diseases, 10:112.

Kanters, T.A., Hakkaart-van Roijen, L., Rutten – van Molken, M.P.M.H. & Redekop, W.K. (2015). Access to orphan drugs in western Europe: can more systematic policymaking really help to avoid different decisions about the same drug? Expert review of pharmacoeconomics & outcomes research, 15 (4), 557-559.

Kanters, T.A., Redekop, W.K., Kruijshaar, M.E., Ploeg, A.T. van der, Rutten – van Molken, M.P.M.H. & Hakkaart-van Roijen, L. (2015). Comparison of EQ-5D and SF-6D utilities in Pompe disease. Quality of Life Research, 24, 837-844. doi: 10.1007/s11136-014-0833-2

Kanters, T.A., Wolff, C., Boyson, D., Kouakam, C., Dinh, T., Hakkaart-van Roijen, L. & Rutten – van Molken, M.P.M.H. (2015). Cost comparison of two implantable cardiac monitors in two different settings: Reveal XT in a catherization laboratory vs. Reveal LINQ in a procedure room. Europace. doi: 10.1093/europace/euv217

Kolk, A, Agthoven, M. van, Buitelaar, J.K. & Hakkaart-van Roijen, L. (2015). A Systematic Review of Literatures on Factors Associated with Educational and Academic Performance in Attention DeficitHyperactivity Disorder. Creative Education, 6, 164-180. doi:

Kraijo, H., Exel, N.J.A. van & Brouwer, W.B.F. (2015). The perseverance time of informal carers for people with dementia: results of a two-year longitudinal follow-up study. BMC Nursing, 14, 56. doi: 10.1186/s12912-015-0107-5

Krol, H.M., Papenburg, J., Tan, S.S., Brouwer, W.B.F. & Hakkaart-van Roijen, L. (2015). A Noticeable Difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs. European Journal of Health Economics (HEPAC).

Krol, H.M., Attema, A.E., Exel, N.J.A. van & Brouwer, W.B.F. (2016). Altruistic preferences in TTO: Consideration of effects on others in health state valuations. Medical Decision Making, 36 (2), 187-198. doi: 10.1177/0272989X15615870

Krol, H.M., Papenburg, J. & Exel, N.J.A. van (2015). Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. Pharmacoeconomics (Print), 33 (2), 123-135. doi:

Kruijssen, V. van, Staa, A.L. van, Dwarswaard, J., Mennema, B. & Adams, S.A. (2015). The use of online self-management diaries for asthma and COPD: A qualitative study of patient and professional perceptions and behaviors. Respiratory Care, 16 (8), 1146-1156. doi:

Labree, L.J.W., Mheen, H. van de, Rutten, F.F.H., Rodenburg, G., Koopmans, G.T. & Foets, M.M.E. (2015). Sleep duration differences between children of migrant and native origins. Journal of Public Health, 23 (3).

Leunis, A.. The cost-effectiveness of personalized medicine strategies in acute myeloid leukemia. EUR. Prom./coprom.: Prof.dr. C.A. Uyl – de Groot, Prof. Dr. B. Lowenberg & dr. W.K. Redekop.

Linden, N. van der, Bongers, M.L., Coupe, V.M.H., Smit, E.F., Groen, H.J.M., Welling, A., Schramel, FMNH & Uyl – de Groot, C.A. (2016). Costs of non-small cell lung cancer in the Netherlands. Lung Cancer, 91, 79-88. doi:

Linden, N. van der, Flach, G.B, Bree, R. de & Uyl – de Groot, C.A. (2016). Cost–utility of sentinel lymph node biopsy in cT1–T2N0 oral cancer. Oral Oncology, 53, 20-26. doi:

Linden, N. van der, Smit, E.F. & Uyl – de Groot, C.A. (2015). Real-world costs of laboratory tests for non-small cell lung cancer. Clinical Chemistry and Laboratory Medicine, 53 (8), e187-e189. doi:

Linden, N. van der, Buter, J., Pescott, C.P., Lalisang, R.I., Boer, JP de, Graeff, A. de, Herpen, C.M.L. van, Baatenburg de Jong, R.J. & Uyl – de Groot, C.A. (2015). Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands. European Archives of Oto-Rhino-Laryngology, 273 (2), 455-464. doi:

Luime, J.J., Buisman, L.R., Oppe, M., Hazes, J.M.W. & Rutten – van Molken, M.P.M.H. (2015). A cost-effectiveness model for evaluating new diagnostic tests in the work-up of patients with inflammatory arthritis at risk of having Rheumatoid Arthritis. Arthritis Care & Research. doi: 10.1002/acr.22776

Lutomski, JE, Exel, N.J.A. van, Kempen, GI, Moll van Charante, EP, Elzen, WPJ den, Jansen, AP, Krabbe, PFM, Steunenberg, B., Steyerberg, E.W., Olde Rikkert, M.G.M. & Melis, RJF (2015). Validation of the Care-Related Quality of Life Instrument in different study settings: findings from The Older Persons and Informal Caregivers Survey Minimum DataSet (TOPICS-MDS). Quality of Life Research, 24 (5), 1281-1293. doi:

Mandrik, O., Knies, S., Golubovska, O., Duda, O., Dudar, L., Fedorchenko, S., Zaliska, O. & Severens, J.L. (2015). Cost comparison of treating chronic hepatitis C genotype one with pegylated interferons in Ukraine. Open : cahier on art and the public domain, 10 (1), 25-33. doi: 10.1515/med-2015-0006

Mandrik, O., Corro Ramos, I., Knies, S., Al, M.J. & Severens, J.L. (2015). Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for treatment of chronic lymphocytic leukemia in Ukraine. Cancer Management and Research (online), 279-289. doi:

Mandrik, O., Knies, S. & Severens, J.L. (2015). Economic value of in vitro fertilization in Ukraine, Belarus, and Kazakhstan. ClinicoEconomics and Outcome Research, 7, 347-356. doi:

Mandrik, O.. Is transferability an issue? Use of economic studies in Ukraine and other central and eastern European countries. EUR. Prom./coprom.: prof.dr. J.L. Severens, O. Zalis’ka & dr. S. Knies.

Maten-Speksnijder, A., Grypdonck, M.G., Pool, A., Meurs, P.L. & Staa, A.L. van (2015). Driven by ambitions. The nurse practitioner’s role transition in Dutch hospital care. Journal of Nursing Scholarship, 47 (6), 544-554. doi:

Maten-Speksnijder, A., Grypdonck, M.G., Pool, A., Meurs, P.L. & Staa, A.L. van (2015). Learning to attain an advanced level of professional responsibility. Nurse Education Today, 35, 954-959. doi:

McHugh, N., Baker, R., Mason, H., Williamson, L., Exel, N.J.A. van, Deogaonkar, R., Collins, M. & Donaldson, C. (2015). Extending life for people with a terminal illness: a moral right and an expensive death? Exploring societal perspectives. BMC Medical Ethics, 16, 14. doi: 10.1186/s12910-015-0008-x

McKay, M.T., Morgan, G.B., Exel, N.J.A. van & Worrell, F.C. (2015). Back to “the Future”: Evidence of a Bifactor Solution for Scores on the Consideration of Future Consequences Scale. Journal of Personality Assessment, 97 (4), 395-402. doi: 10.1080/00223891.2014.999338

Mohseninejad, L., Gils, C.W.M. van, Uyl – de Groot, C.A., Buskens, E. & Feenstra, T. (2015). Evaluation of Patient Registries Supporting Reimbursement Decisions: The Case of Oxaliplatin for Treatment of Stage III Colon Cancer. Value in Health, 18, 84-90. doi:

Neelsen, S., Limwattananon, S., O’Donnell, O.A. & Doorslaer, E.K.A. van (2015). Economic Impact of Illness with Health Insurance but without Income Insurance. (Working Paper, TI Discussion Paper, no TI 2015-060/V). : Tinbergen Institute.

Otten, E., Birnie, E., Ranchor, A.V., van Tintelen, J.P. & van Langen, I.M. (2015). A group approach to genetic counselling of cardiomyopathy patients: Satisfaction and psychological outcomes sufficient for further implementation. European Journal of Human Genetics.

Otten, E., Plantinga, M, Birnie, E., Verkerk, M.A., Lucassen, A.M., Ranchor, A.V. & van Langen, I.M. (2015). Is there a duty to recontact in light of new genetic technologies? A systematic review of the literature. Genetics in Medicine, 17 (8), 668-678.

Otten, E., Birnie, E., Lucassen, A.M., Ranchor, A.V. & van Langen, I.M. (2015). Telemedicine uptake among Genetics Professionals in Europe: room for expansion. European Journal of Human Genetics.

Pennington, M., Baker, R., Brouwer, W.B.F., Mason, H., Gyrd Hansen, D., Robinson, A. & Donaldson, C. (2015). Comparing WTP values of different types of QALY gain elicited from the general public. Health Economics, 24 (3), 280-293. doi: Health Economics 2015; 24(3): 280-293

Poel, E. van de, Flores, G, Ir, P. & O’Donnell, O (2015). Impact of performance based financing in a low resource setting: A decade of experience in Cambodia. Health Economics. doi: 10.1002/hec.3219

Poeran, J, Borsboom, G.J.J.M., Graaf, J.P. de, Birnie, E., Steegers, E.A.P. & Bonsel, G.J. (2015). Population Attributable Risks of Patient, Child and Organizational Risk Factors for Perinatal Mortality in Hospital Births. Maternal and Child Health Journal, 19 (4), 764-775. doi: 10.1007/s10995-014-1562-4

Prick, B.W., Duvekot, J.J., Moer, P.E. van der, Gemund, N. van, Salm, P.C.M. van der, Jansen, A.J.G., Rhenen, D.J. van, Mol, BW & Uyl – de Groot, C.A. (2014). Cost-effectiveness of red blood cell transfusion vs. non-intervention in women with acute anaemia after postpartum haemorrhage. Vox Sanguinis, 107, 381-388. doi: 10.1111/vox.12181

Quintussi, M, Poel, E. van de, Panda, P. & Rutten, F.F.H. (2015). Economic consequences of ill-health for households in northern rural India. Bmc Health Services Research, 15, 179. doi: 10.1186/s 12913-015-0833-0

Rappange, D.R., Exel, N.J.A. van & Brouwer, W.B.F. (2015). A long life in good health: Subjective expectations regarding length and future health-related quality of life. European Journal of Health Economics (HEPAC). doi: 10.1007/s10198-015-0701-1

Raza, W., Poel, E. van de, Bedi, A. & Rutten, F. (2016). Impact of Community-based Health Insurance on Access and Financial Protection: Evidence from Three Randomized Control Trials in Rural India. Health Economics. doi: 10.1002/hec.3307

Raza, W.A., Poel, E. van de, Panda, P. & Dror, D. (2016). Healthcare seeking behaviour among self-help group households in Rural Bihar and Uttar Pradesh, India. Bmc Health Services Research, 16 (1). doi: 10.1186/s 12913-015-1254-9

Romijn, G., Riper, H., Kok, R., Donker, T., Goorden, M., Hakkaart-van Roijen, L., Kooistra, L, Balkom, A van & Koning, J. (2015). Cost-effectiveness of blended vs. face-to-face cognitive behavioural therapy for severe anxiety disorders: study protocol of a randomized contolled trial. BioMed Central, 15 (311), 1-10. doi:

Rutz, S.I., Mathew, D, Robben, P.B.M. & Bont, A.A. de (2015). Enhancing responsiveness and consistency: Comparing the collective use of discretion and discretionary room at inspectorates in England and the Netherlands. Regulation & Governance. doi: 10.1111/rego.12101

Schawo, S.J., van der Kolk, A., Bouwmans, C.A.M., Annemans, L., Postma, M.J., Buitelaar, J., van Agthoven, M. & Hakkaart-van Roijen, L. (2015). Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed? Pharmacoeconomics (Online). doi: 10.1007/s40273-015-0259-x

Schuurman, A.G., van der Kolk, D.M., Verkerk, M.A., Birnie, E., Ranchor, A.V., Plantinga, M & van Langen, I.M. (2015). Maximising the efficiency of clinical screening programmes: Balancing predictive genetic testing with a right not to know. European Journal of Human Genetics, 23 (9), 1124-1128.

Slotman, A., Cramm, J.M. & Nieboer, A.P. (2015). Validation of the Dutch Aging Perceptions Questionnaire and development of a short version. Health and Quality of Life Outcomes, 13:54. doi:

Staa, A.L. van, Sattoe, J.N.T. & Strating, M.M.H. (2015). Experiences with and outcomes of two interventions to maximize engagement of chronically ill adolescents during hospital consultations: A mixed methods study.. Journal of Pediatric Nursing, 30 (5), 757-775. doi: 10.1016/j.pedn.2015.05.028

Stoep, D.F. van der, Zeben, D van, Klop, B., Geijn, G.J.M. van de, Janssen, HJW, Hazes, J.M.W., Birnie, E., Meulen, N van der, Vries, M.A. de & Cabezas, MC (2015). Association of Cardiovascular Risk Factors with Carotid Intima Media Thickness in Patients with Rheumatoid Arthritis with Low Disease Activity Compared to Controls: A Cross-Sectional Study. PLoS One (print), 10 (10). doi: 10.1371/journal.pone.0140844

Tan, S.S., Teirlinck, CH, Dekker, J., Goossens, L.M.A., Bohnen, A.M., Verhaar, J.A.N., Van Es, P.P., Koes, B.W., Bierma-Zeinstra, S.M.A., Luijsterburg, P.A.J. & Koopmanschap, M.A. (2015). Cost-utility of exercise therapy in patients with hip osteoarthritis in primary care. Osteoarthritis and Cartilage.

Tilling, C.J., Krol, H.M., Attema, A.E., Tsuchiya, A., Brazier, J., Exel, N.J.A. van & Brouwer, W.B.F. (2015). Exploring a new method for deriving the Monetary Value of a QALY. European Journal of Health Economics (HEPAC). doi: 10.1007/s10198-015-0722-9

Tran Duy, An, Boonen, A., Laar, MAFJ van de & Severens, J.L. (2015). Impact on total population health and societal cost-effectiveness of including tumour necrosis factor- antagonists in management of ankylosing spondylitis: a dynamic population modelling study. Cost Effectiveness and Resource Allocation. doi: 10.1186/s12962-015-0044-x

Tsiachristas, A., Wallenburg, I., Bond, C.M., Elliot, R.F., Busse, R., Exel, N.J.A. van, Rutten – van Molken, M.P.M.H. & Bont, A.A. de (2015). Costs and effects of new professional roles: evidence from a literature review. Health Policy, 119 (9), 1176-1187. doi: 10.1016/j.healthpol.2015.04.001

Tsiachristas, A. (2015, March 20). Payment and Economic Evaluation of Integrated Care. EUR (253 pag.) (Rotterdam). Prom./coprom.: Prof.Dr. M.P.M.H. van Molken.

Uyl – de Groot, C.A., Brouwer, W.B.F., Maeseneer, M.G.R. de & Verweij, J. (2015). Primary care in cancer control: towards mature cancer care. Lancet Oncology, 16 (22), 1226-1227. doi:

Van Nooten, F., Exel, N.J.A. van, koolman, AHE & Brouwer, W.B.F. (2015). “Married with children”: The influence of significant others in TTO exercises. Health and Quality of Life Outcomes, 13, 94. doi: 10.1186/s12955-015-0276-7

Vos, J.B.M. de, Asmus, K.J.E., Bakker, T.J.E.M., Vreede, P.L. de, Wijngaarden, J.D.H. van, Steyenberg, E.W., Mackenbach, J.P. & Nieboer, A.P. (2015). Integrale interventie ter voorkoming van functieverlies bij ouderen tijdens ziekenhuisopname: het Zorgprogramma voor Preventie en Herstel. Tijdschrift voor Gerontologie en Geriatrie, 46 (1), 12-27.

Wagstaff, A., Dmytraczenko, T., Almeida, G., Buisman, L.R., Hoang-Vu Eozenou, P., Bredenkamp, C., Cercone, J.A., Diaz, Y., Maceira, D., Molina, S., Paraje, G., Ruiz, F., Sarti, F., Scott, J, Valdivia, M. & Werneck, H. (2015). Assessing Latin America’s Progress Toward Achieving Universal Health Coverage. Health Affairs, 34 (10), 1704-1712. doi:

Wagstaff, A., Cotlear, D., Hoang-Vu Eozenou, P. & Buisman, L.R. (2016). Measuring progress towards universal health coverage: with an application to 24 developing countries. Oxford Review of Economic Policy, 32 (1), 147-189. doi:

Wagstaff, A., Cotlear, D., Hoang-Vu Eozenou, P. & Buisman, L.R. (2015). Measuring Progress towards Universal Health Coverage : With an Application to 24 Developing Countries. (Working Paper, Policy Research Working Paper, no 7470). : World Bank.

Weggelaar, AM, Bovenkamp, H.M. van de & Bal, R.A. (2016). Zand in de kwaliteitsmachinerie. Medisch Contact, April 2016, 36-38.

Westwood, M., Asselt, T., Ramaekers, Bram, Whiting, Penny, Thokala, Praveen, Joore, M.A., Armstrong, N, Ross, J., Severens, J.L. & Kleijnen, J. (2015). High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people eith acute chest pain: a systematic review and cost-effectiveness analysis. Health Technology Assessment, 19 (44). doi:

Westwood, M., Ramaekers, Bram, Whiting, Penny, Tomini, F., Joore, M.A., Armstrong, N, Ryder, S, Strik, Lisa, Severens, J.L. & Kleijnen, J. (2015). Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings_a systematic review and cost-effectiveness analysis. (External report, 19, no 96). : Health Technology Assessment.

Wetering, E.J. van de, Exel, N.J.A. van, Bobinac, A. & Brouwer, W.B.F. (2015). Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment. Pharmacoeconomics (Print). doi: 10.1007/s40273-015-0311-x

Wouters, S., Exel, N.J.A. van, Rohde, K.I.M. & Brouwer, W.B.F. (2015). Are all health gains equally important?  An exploration of acceptable health as reference point in health care priority setting. Health and Quality of Life Outcomes, 13, 79. doi:

Wouters, S., Exel, N.J.A. van, van de Donk, M., Rohde, K.I.M. & Brouwer, W.B.F. (2015). Do people desire to be healthier than other people? A short note on positional concerns for health. European Journal of Health Economics (HEPAC), 16 (1), 47-54. doi:

Wubulihasimu, P., Brouwer, W.B.F. & Baal, P.H.M. van (2015). Does living longer in good health facilitate longer working lives? The relationship between disability and working lives. European Journal of Public Health, 25 (5), 791-795. doi: 10.1093/eurpub/ckv062.

Wubulihasimu, P., Brouwer, W.B.F. & Baal, P.H.M. van (2015). The Impact of Hospital Payment Schemes on Healthcare and Mortality: Evidence from Hospital Payment Reforms in OECD Countries. Health Economics. doi:

de Kleijn, R., Hagen, C, Uyl – de Groot, C.A., Pasker de Jong, P. & Wee, P Ter (2015). PREDICTION OF CARE BURDEN OF PATIENTS UNDERGOING HAEMODIALYSIS: DEVELOPMENT OF A MEASURING TOOL. Journal of Renal care, 1-7. doi:

van Gils, C.W.M., Groot, S. de, Tan, S.S., Redekop, W.K., Koopman, M, Punt, CJ & Uyl – de Groot, C.A. (2013). Real-world resource use and costs of adjuvant treatment for stage III colon cancer. European Journal of Cancer Care. doi: 10.1111/ecc.12154

van der Kolk, A., Bouwmans, C.A.M., Schawo, S.J., Buitelaar, J.K., Agthoven, M. van & Hakkaart-van Roijen, L. (2015). Association between societal costs and treatment response in children and adolescents with ADHD and their parents. A cross-sectional study in the Netherlands. SpringerPlus, 4, 224. doi: 10.1186/s40064-015-0978-7

van der Weijden, T., Dreessens, D. & Bovenkamp, H.M. van de (2016). Gedeelde besluitvorming en richtlijnen. utrecht: Handboek evidence based richtlijnontwikkeling.